Immune to Cancer: The CRI Blog
-
Immunotherapy for Blood Cancers: What to Look for at the Upcoming ASH Meeting
Look for the latest results from trials of PD-1 inhibitors and new developments in adoptive cell transfer.
-
Found: A Molecular Needle in the Cancer Haystack
New research by CRI scientists shows how genomic methods can be used to create a personalized cancer…
-
Birth of the Lab Mouse
Was the father of cancer immunotherapy also the father of the modern lab mouse?
-
CAR T Cell Therapy Surges Forward
Researchers at the University of Pennsylvania publish latest results on an experimental immunotherapy using genetically engineered T…
-
The Arrival of Personalized Immunotherapy?
A new paper from a CRI scientist makes a strong case f or the value of truly…
-
Uncovering Cancer Targets
The CRI Young Philanthropist Fellow's research on gene expression in cancer could impact the way lymphoma is…
-
AACR Report Highlights Cancer Immunotherapy
The AACR Cancer Progress Report provides a "state-of-the-union" look at where we are in cancer research.
-
Coast to Coast for a Cure
Cyclist Joel Paula biked 4,000 miles to raise money for the Cancer Research Institute, and to prove…
-
FDA Approves New Cancer Immunotherapy
Merck's new immunotherapy, Keytruda (pembrolizumab), was approved today by the FDA, making it the first PD-1 inhibitor…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.